Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas

Epigenetics is involved in tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that the DNA methylation profiling may predict the clinical behavior of metastatic CRCs (mCRCs). The global methylation profile of two human mCRC subgroups with s...

Full description

Bibliographic Details
Main Authors: Valentina Condelli, Giovanni Calice, Alessandra Cassano, Michele Basso, Maria Grazia Rodriquenz, Angela Zupa, Francesca Maddalena, Fabiana Crispo, Michele Pietrafesa, Michele Aieta, Alessandro Sgambato, Giampaolo Tortora, Pietro Zoppoli, Matteo Landriscina
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/1/158
_version_ 1797542321863000064
author Valentina Condelli
Giovanni Calice
Alessandra Cassano
Michele Basso
Maria Grazia Rodriquenz
Angela Zupa
Francesca Maddalena
Fabiana Crispo
Michele Pietrafesa
Michele Aieta
Alessandro Sgambato
Giampaolo Tortora
Pietro Zoppoli
Matteo Landriscina
author_facet Valentina Condelli
Giovanni Calice
Alessandra Cassano
Michele Basso
Maria Grazia Rodriquenz
Angela Zupa
Francesca Maddalena
Fabiana Crispo
Michele Pietrafesa
Michele Aieta
Alessandro Sgambato
Giampaolo Tortora
Pietro Zoppoli
Matteo Landriscina
author_sort Valentina Condelli
collection DOAJ
description Epigenetics is involved in tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that the DNA methylation profiling may predict the clinical behavior of metastatic CRCs (mCRCs). The global methylation profile of two human mCRC subgroups with significantly different outcome was analyzed and compared with gene expression and methylation data from The Cancer Genome Atlas COlon ADenocarcinoma (TCGA COAD) and the NCBI GENE expression Omnibus repository (GEO) GSE48684 mCRCs datasets to identify a prognostic signature of functionally methylated genes. A novel epigenetic signature of eight hypermethylated genes was characterized that was able to identify mCRCs with poor prognosis, which had a CpG-island methylator phenotype (CIMP)-high and microsatellite instability (MSI)-like phenotype. Interestingly, methylation events were enriched in genes located on the q-arm of chromosomes 13 and 20, two chromosomal regions with gain/loss alterations associated with adenoma-to-carcinoma progression. Finally, the expression of the eight-genes signature and MSI-enriching genes was confirmed in oxaliplatin- and irinotecan-resistant CRC cell lines. These data reveal that the hypermethylation of specific genes may provide prognostic information that is able to identify a subgroup of mCRCs with poor prognosis.
first_indexed 2024-03-10T13:27:55Z
format Article
id doaj.art-4e8c7b192e1b495ba1e4c7a35076fe0f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T13:27:55Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-4e8c7b192e1b495ba1e4c7a35076fe0f2023-11-21T08:30:51ZengMDPI AGCancers2072-66942021-01-0113115810.3390/cancers13010158Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal CarcinomasValentina Condelli0Giovanni Calice1Alessandra Cassano2Michele Basso3Maria Grazia Rodriquenz4Angela Zupa5Francesca Maddalena6Fabiana Crispo7Michele Pietrafesa8Michele Aieta9Alessandro Sgambato10Giampaolo Tortora11Pietro Zoppoli12Matteo Landriscina13Laboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyMedical Oncology Unit, Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyMedical Oncology Unit, Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyMedical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyPathology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyMedical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyMedical Oncology Unit, Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyLaboratory of Preclinical and Translational Research, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Potenza, ItalyEpigenetics is involved in tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that the DNA methylation profiling may predict the clinical behavior of metastatic CRCs (mCRCs). The global methylation profile of two human mCRC subgroups with significantly different outcome was analyzed and compared with gene expression and methylation data from The Cancer Genome Atlas COlon ADenocarcinoma (TCGA COAD) and the NCBI GENE expression Omnibus repository (GEO) GSE48684 mCRCs datasets to identify a prognostic signature of functionally methylated genes. A novel epigenetic signature of eight hypermethylated genes was characterized that was able to identify mCRCs with poor prognosis, which had a CpG-island methylator phenotype (CIMP)-high and microsatellite instability (MSI)-like phenotype. Interestingly, methylation events were enriched in genes located on the q-arm of chromosomes 13 and 20, two chromosomal regions with gain/loss alterations associated with adenoma-to-carcinoma progression. Finally, the expression of the eight-genes signature and MSI-enriching genes was confirmed in oxaliplatin- and irinotecan-resistant CRC cell lines. These data reveal that the hypermethylation of specific genes may provide prognostic information that is able to identify a subgroup of mCRCs with poor prognosis.https://www.mdpi.com/2072-6694/13/1/158promoter methylationcolorectal carcinomagene signatureprognosisMSI-like signatureCIMP status
spellingShingle Valentina Condelli
Giovanni Calice
Alessandra Cassano
Michele Basso
Maria Grazia Rodriquenz
Angela Zupa
Francesca Maddalena
Fabiana Crispo
Michele Pietrafesa
Michele Aieta
Alessandro Sgambato
Giampaolo Tortora
Pietro Zoppoli
Matteo Landriscina
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
Cancers
promoter methylation
colorectal carcinoma
gene signature
prognosis
MSI-like signature
CIMP status
title Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
title_full Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
title_fullStr Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
title_full_unstemmed Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
title_short Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
title_sort novel epigenetic eight gene signature predictive of poor prognosis and msi like phenotype in human metastatic colorectal carcinomas
topic promoter methylation
colorectal carcinoma
gene signature
prognosis
MSI-like signature
CIMP status
url https://www.mdpi.com/2072-6694/13/1/158
work_keys_str_mv AT valentinacondelli novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT giovannicalice novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT alessandracassano novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT michelebasso novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT mariagraziarodriquenz novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT angelazupa novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT francescamaddalena novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT fabianacrispo novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT michelepietrafesa novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT micheleaieta novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT alessandrosgambato novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT giampaolotortora novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT pietrozoppoli novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas
AT matteolandriscina novelepigeneticeightgenesignaturepredictiveofpoorprognosisandmsilikephenotypeinhumanmetastaticcolorectalcarcinomas